The U.S. Supreme Court overturned a significant ruling against Monsanto on June 25th, potentially jeopardizing thousands of lawsuits. The original case involved a Missouri farmer who successfully sued the agrochemical giant, alleging that its Roundup herbicide caused his cancer. This initial victory spurred tens of thousands of similar complaints against the American subsidiary of Bayer. The Supreme Court’s decision effectively opens the door for the dismissal of these pending claims. The ruling centers on jurisdictional issues and whether all plaintiffs meet the requirements to sue in the specific court where the initial case was heard. Bayer’s stock rose following the announcement, indicating investor confidence. This decision represents a major setback for those seeking compensation for alleged Roundup-related illnesses.